IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes – biolegacy

IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

Post author:Sam
Post published:November 9, 2017
Post category:BioPharma

ImmunoMolecular Therapeputics officially launched yesterday.
Source: BioSpace